Top Markets
#1 TENDIES TENDIES +37.02%
#2 Cash Cat Cash Cat +24.00%
#3 Asteroid Shiba Asteroid Shiba +16.86%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.30%
#6 Bluwhale Bluwhale +10.73%
#7 MarsCoin MarsCoin +8.62%
#8 ROLL ROLL +7.54%
#9 CARV CARV +7.24%
#10 Pyth Network Pyth Network +7.13%
Coin of the day
TENDIES TENDIES
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Carvolix S.A. Carvolix S.A.

Carvolix S.A.

CVX
Pozycja w akcjach #16547
Carvolix S.A. operates as a medical technology firm, concurrently involved in... Carvolix S.A. operates as a medical technology firm, concurrently involved in both commercialization and clinical development, specializing in treatment solutions for structural heart ailments and cerebral strokes. The company's innovative endeavors encompass the creation of AI- and imaging-driven mini-robots, engineered for executing intricate medical procedures, as well as the development of biomimetic heart valves. Established on January 30, 2026, Carvolix S.A. maintains its headquarters in Aix-en-Provence, France.
Cena akcji
$7.31
Ostatnia synchronizacja: 2026-09-01
Kapitalizacja rynkowa
$286.87M
Zmiana (1 dzień)
-1.91%
Zmiana (1 rok)
310.35%
Kraj
FR
Handel Carvolix S.A. (CVX)

Kategoria

Healthcare
Historia stopy dywidendy dla Carvolix S.A. (CVX)
Stopa dywidendy (TTM) dla Carvolix S.A. (symbol akcji: CVX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Carvolix S.A. (CVX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.25%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.07%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US